Investigating how systemic racism affects breast cancer mortality in Black women
Systemic Racism and Biological Embodiment of Risk in Breast Cancer Mortality
This study is looking at how the effects of systemic racism might contribute to higher breast cancer death rates among Black women in the U.S., and it will involve nearly 5,200 women with breast cancer to better understand this important issue.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10911173 on NIH RePORTER |
What this research studies
This research focuses on understanding the higher rates of breast cancer mortality among Black women in the U.S. by examining the impact of systemic racism. It aims to explore how chronic exposure to systemic racism may lead to biological changes that increase health risks. The study will create a new cohort of nearly 5,200 participants, including women diagnosed with breast cancer, to analyze the relationship between systemic racism and breast cancer outcomes. By integrating data from existing cohorts, the research will provide a comprehensive view of how social factors influence health.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women who have been diagnosed with breast cancer or are at risk of developing it.
Not a fit: Patients who are not Black or do not have a diagnosis of breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and interventions that reduce breast cancer mortality in Black women.
How similar studies have performed: While the examination of systemic racism's impact on health is gaining attention, this specific approach has not been empirically tested in a single cohort before, making it a novel investigation.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Akinyemiju, Tomi F — Duke University
- Study coordinator: Akinyemiju, Tomi F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.